ClinicalTrials.gg
CompletedNCT02550626Updated Feb 15, 2019

Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery

An observational study in Post-operation Delirium and Alpha-synucleinopathy Related Non-motor Symptom, sponsored by Yonsei University. Completed at 1 site in Korea, Republic of. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-02-15.

Sponsored by Yonsei University · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
106
Ages
65 Years and older
Sex
All
01

Study summary

Hypothesis is that the presence of a-synucleinopathy related non motor symptoms could be predictive factor for post-operative delirium. During 72hrs after spine surgery, investigator will observe occurrence of post-operative delirium, and analysis difference of a-synucleinopathy related non motor symptoms between 2 groups.

Read the detailed description

Postoperative delirium appear approximately 10-70% of patients older than 65 yrs undergoing surgery and it is strongly associated with poor surgical outcome. The clinical characteristics of postoperative delirium are fluctuating attention, visual hallucination, disorganized thought and alter sleep-wake cycles. This is quite similar to core features of α-synuclein-related cognitive disorders such as parkinson's disease dementia and dementia with lewy body. At that point, investigator thought that postoperative delirium is preclinical stage of a-synucleinopathy. In other words, a-synuclein related disorders and postoperative delirium may share an underlying neurochemical change in their pathogenesis.

investigator will recruit age 65 and older patients scheduled to perform spine surgery. The pre-operative evaluation include neurologic exam, baseline cognitive function and a-synucleinopathy related non motor symptoms through Questionnaires.

02

Conditions studied

  • Post-operation Delirium
  • Alpha-synucleinopathy Related Non-motor Symptom

Keywords

  • delirium
  • alpha synucleinopathy
  • spine surgery
03

In context

Delirium

933 studies on the registry are indexed under Delirium; 190 are open to participants now.

This study's enrollment of 106 is below the median of 194 across 342 observational studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Yonsei University is the lead sponsor of 1,418 studies on the registry; 241 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

spine surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 65 and older patients
  2. Scheduled to perform spine surgery in severance hospital

Exclusion criteria

Exclusion Criteria:

  1. Previous delirium history
  2. Previous chemotherapy or radiotherapy within 1yr due to underlying cancer.
  3. Severe hepatic/renal dysfunction
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
106 participants (actual)
Patient registry
No

Groups and cohorts

  • Delirium

    occurrence of post-operative delirium

  • No delirium

    no presence of post-operative delirium

06

What researchers measure

Primary outcomes

  1. existence of anosomia

    During 72hrs after spine surgery, investigator will observe occurrence of post-operative delirium, and analysis difference of anosmia symptoms before operation between 2 groups. The cross-cultural smell identification test will be used for measure of anosmia. investigator define anosmia as less than 4 score on the cross-cultural smell identification test. This study is not interventional study, because measure of anosmia by smell kit will not develop post-operation delirium more. (investigator will classify our patients into normosmia if the CCSIT score is 9 or higher, and hyposmia if the CCSIT score is 6 or less. Patients whose CCSIT scores are 7 or 8 will be regarded as borderline.).

    Time frame: A day before operation

Secondary outcomes

  1. existence of constipation

    Questionnaire (Constipation scoring system (Agachanet al., 1996) \& Rome III Questionnaire (Constipation : Yes/No)

    Time frame: A day before operation

  2. existence of orthostatic hypotension

    Check 3 position BP (define orthostatic hypotension - sustained reduction of systolic blood pressure of at least 20 mmHg or diastolic blood pressure of 10 mmHg within 3 min of standing, / Questionnaire (orthostatic hypotension symptom assessment \& Orthostatic hypotension daily activities scale) (orthostatic hypotension: Yes/No)

    Time frame: A day before operation

  3. existence of insomnia

    Questionnaire (Epworth Sleepiness Scale (ESS) : total score 0-24)

    Time frame: A day before operation

  4. existence of depression

    Questionnaire (Beck depression inventory, total score 0-63)

    Time frame: A day before operation

  5. existence of anxiety

    Questionnaire (The Parkinson Anxiety Scale, total score 0-48)

    Time frame: A day before operation

  6. existence of REM sleep behavior disorder

    Questionnaire (RBD screening questionnaire, total score 0-13) :These questionnaires \& checking 3-position BP will not effect the occurence of post-operation delirium

    Time frame: A day before operation

07

Study locations

1 site
  • Department of Neurology, Yonsei University College of Medicine
    Seoul, Seou 120-752, Korea, Republic of
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Oct 2015, a primary completion of Aug 2016 and a completion of Aug 2016. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 16, 2015
First posted
Sep 15, 2015
Start
Oct 2015
Primary completionActual
Aug 2016
CompletionActual
Aug 2016
Last update
Feb 15, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02550626
Lead sponsor
Yonsei University
Responsible party
Sponsor
First posted
Sep 15, 2015
Start date
Oct 2015
Primary completion
Aug 2016
Completion
Aug 2016
Last update
Feb 15, 2019

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion